This inventor holds 3 USPTO granted patents. Top assignees: Dynatech Corporation, Key Pharmaceuticals, Inc., Schering Corporation. Active years: 1988-1989.
Company Filing History:
1 out of 17 
1 out of 54 
1 out of 1,829 
Years Active: 1988-1989
Title: John E Sanderson: Innovator in Transdermal Drug Delivery
Introduction
John E Sanderson is a notable inventor based in North Miami, FL (US). He has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. His work focuses on innovative methods for administering medications transdermally, which can enhance patient care and treatment efficacy.
Latest Patents
Among his latest patents, Sanderson has developed a method for the transdermal delivery of enantiomers of phenylpropanolamine. This method aims to induce anorexia or nasal decongestion by transdermally administering an enantiomer of phenylpropanolamine. Additionally, he has patented a method and apparatus for iontophoretic drug delivery. This device is designed for the iontophoretic delivery of active ingredients to patients, featuring an electrode and a specialized cavity for holding a solution of the active ingredient. The invention also includes an ion exchange member that inhibits the flow of ions with a charge similar to that of the ionized form of the active ingredient.
Career Highlights
Throughout his career, John E Sanderson has worked with prominent companies such as Dynatech Corporation and Key Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug delivery technologies and innovation.
Collaborations
One of his notable collaborators is Stanton R Deriel, with whom he has worked on various projects related to drug delivery systems.
Conclusion
John E Sanderson's contributions to the field of transdermal drug delivery highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical technology and enhancing treatment options for patients.